Rocco, D., Friedlaender, A., Addeo, A., Signorelli, D., Cortellini, A., Buti, S., . . . Petrelli, F. Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: A multicenter study with external validation. BMJ Publishing Group.
Chicago Style (17th ed.) CitationRocco, Danilo, et al. Baseline BMI and BMI Variation During First Line Pembrolizumab in NSCLC Patients with a PD-L1 Expression ≥ 50%: A Multicenter Study with External Validation. BMJ Publishing Group.
MLA (9th ed.) CitationRocco, Danilo, et al. Baseline BMI and BMI Variation During First Line Pembrolizumab in NSCLC Patients with a PD-L1 Expression ≥ 50%: A Multicenter Study with External Validation. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.